MESA LABORATORIES INCMLABEarnings & Financial Report
Mesa Laboratories Inc. develops, manufactures and sells professional quality control, calibration and monitoring instruments as well as related supporting services. Its core offerings cater to healthcare, pharmaceutical, food and beverage, industrial hygiene and environmental testing markets, helping global clients meet regulatory compliance and operational safety requirements.
Revenue
$62.8M
Gross Profit
$39.8M
Operating Profit
$5.8M
Net Profit
$-1.7M
Gross Margin
63.3%
Operating Margin
9.2%
Net Margin
-2.7%
YoY Growth
17.5%
EPS
$-0.31
MESA LABORATORIES INC Q3 FY2025 Financial Summary
MESA LABORATORIES INC reported revenue of $62.8M (up 17.5% YoY) for Q3 FY2025, with a net profit of $-1.7M (down 179.2% YoY) (-2.7% margin). Cost of goods sold was $23.1M, operating expenses totaled $34.0M.
Key Financial Metrics
| Total Revenue | $62.8M |
|---|---|
| Net Profit | $-1.7M |
| Gross Margin | 63.3% |
| Operating Margin | 9.2% |
| Report Period | Q3 FY2025 |
Revenue Breakdown
MESA LABORATORIES INC Q3 FY2025 revenue of $62.8M breaks down across 4 segments, led by Sterilization And Disinfection Control at $23.5M (37.4% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sterilization And Disinfection Control | $23.5M | 37.4% |
| Calibration Solutions | $14.4M | 23.0% |
| Clinical Genomics | $12.7M | 20.2% |
| Biopharmaceutical Development | $12.2M | 19.5% |
MESA LABORATORIES INC Revenue by Segment — Quarterly Trend
MESA LABORATORIES INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Sterilization And Disinfection Control and Calibration Solutions) has evolved quarter over quarter.
| Segment | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Sterilization And Disinfection Control | $24.9M | $22.1M | $25.4M | $24.7M |
| Calibration Solutions | — | — | $12.3M | — |
| Clinical Genomics | $11.8M | $11.1M | $10.3M | $11.5M |
| Biopharmaceutical Development | $14.4M | $13.9M | $11.5M | — |
MESA LABORATORIES INC Annual Revenue by Year
MESA LABORATORIES INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $241.0M).
| Year | Annual Revenue |
|---|---|
| 2025 | $241.0M |
| 2024 | $216.2M |
| 2023 | $219.1M |
| 2022 | $184.3M |
MESA LABORATORIES INC Quarterly Revenue & Net Profit History
MESA LABORATORIES INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q3 FY2026 | $65.1M | +3.6% | $3.6M | 5.6% |
| Q2 FY2026 | $60.7M | +5.0% | $2.5M | 4.1% |
| Q1 FY2026 | $59.5M | +2.4% | $4.7M | 8.0% |
| Q4 FY2025 | $62.1M | +5.5% | $-7.1M | -11.4% |
| Q3 FY2025 | $62.8M | +17.5% | $-1.7M | -2.7% |
| Q2 FY2025 | $57.8M | +8.8% | $3.4M | 5.9% |
| Q1 FY2025 | $58.2M | +14.9% | $3.4M | 5.8% |
| Q4 FY2024 | $58.9M | +6.0% | $-254.6M | -432.2% |
Income Statement
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $58.9M | $58.2M | $57.8M | $62.8M | $62.1M | $59.5M | $60.7M | $65.1M |
| YoY Growth | 6.0% | 14.9% | 8.8% | 17.5% | 5.5% | 2.4% | 5.0% | 3.6% |
Balance Sheet
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $446.8M | $440.4M | $454.1M | $433.3M | $433.3M | $435.7M | $430.4M | $434.8M |
| Liabilities | $301.4M | $289.6M | $292.6M | $273.5M | $273.5M | $263.2M | $251.9M | $248.2M |
| Equity | $145.4M | $150.7M | $161.5M | $155.2M | $159.8M | $172.5M | $178.5M | $186.7M |
Cash Flow
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $12.9M | $10.7M | $5.3M | $18.1M | $12.7M | $1.9M | $8.2M | $18.8M |